The latest closing stock price for Telomir Pharmaceuticals as of January 21, 2025 is 4.93.
An investor who bought $1,000 worth of Telomir Pharmaceuticals stock at the IPO in 2024 would have $-14 today, roughly 0 times their original investment - a -1.40% compound annual growth rate over 1 years.
The all-time high Telomir Pharmaceuticals stock closing price was 11.90 on February 14, 2024.
The Telomir Pharmaceuticals 52-week high stock price is 20.72, which is 320.3% above the current share price.
The Telomir Pharmaceuticals 52-week low stock price is 3.11, which is 36.9% below the current share price.
The average Telomir Pharmaceuticals stock price for the last 52 weeks is 5.56.
An investor who bought $1,000 worth of Telomir Pharmaceuticals stock at the IPO in 2024 would have $-14 today, roughly 0 times their original investment - a -1.40% compound annual growth rate over 1 years.
The all-time high Telomir Pharmaceuticals stock closing price was 11.90 on February 14, 2024.
The Telomir Pharmaceuticals 52-week high stock price is 20.72, which is 320.3% above the current share price.
The Telomir Pharmaceuticals 52-week low stock price is 3.11, which is 36.9% below the current share price.
The average Telomir Pharmaceuticals stock price for the last 52 weeks is 5.56.